Skip to content

BNTX

BioNTech SE

Key figures

MetricLatest5-year CAGR
Revenue€2.9B2025+42.9%
Gross profit€91M2019—
Operating income−€1.4B2025—
Net income−€1.1B2025—
EPS−€4.702025—
Free cash flow€281M2025—